SMA SOLAR TECHNOLOGY AG (S92.DE) Fundamental Analysis & Valuation

FRA:S92 • DE000A0DJ6J9

Current stock price

52.5 EUR
+3.2 (+6.49%)
Last:

This S92.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. S92.DE Profitability Analysis

1.1 Basic Checks

  • In the past year S92 has reported negative net income.
  • S92 had a positive operating cash flow in the past year.
  • In multiple years S92 reported negative net income over the last 5 years.
  • S92 had a positive operating cash flow in 4 of the past 5 years.
S92.DE Yearly Net Income VS EBIT VS OCF VS FCFS92.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • The Return On Assets of S92 (-13.87%) is worse than 82.19% of its industry peers.
  • The Return On Equity of S92 (-49.55%) is worse than 83.56% of its industry peers.
Industry RankSector Rank
ROA -13.87%
ROE -49.55%
ROIC N/A
ROA(3y)-2.53%
ROA(5y)-0.95%
ROE(3y)-12.65%
ROE(5y)-6.32%
ROIC(3y)N/A
ROIC(5y)N/A
S92.DE Yearly ROA, ROE, ROICS92.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • S92 has a Gross Margin of 8.09%. This is amonst the worse of the industry: S92 underperforms 90.41% of its industry peers.
  • S92's Gross Margin has declined in the last couple of years.
  • S92 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.4%
GM growth 5Y-4.74%
S92.DE Yearly Profit, Operating, Gross MarginsS92.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. S92.DE Health Analysis

2.1 Basic Checks

  • S92 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • S92 has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, S92 has about the same amount of shares outstanding.
  • The debt/assets ratio for S92 has been reduced compared to a year ago.
S92.DE Yearly Shares OutstandingS92.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
S92.DE Yearly Total Debt VS Total AssetsS92.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • S92 has an Altman-Z score of 2.11. This is not the best score and indicates that S92 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.11, S92 perfoms like the industry average, outperforming 53.42% of the companies in the same industry.
  • S92 has a debt to FCF ratio of 1.50. This is a very positive value and a sign of high solvency as it would only need 1.50 years to pay back of all of its debts.
  • S92 has a Debt to FCF ratio of 1.50. This is amongst the best in the industry. S92 outperforms 86.30% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that S92 is not too dependend on debt financing.
  • The Debt to Equity ratio of S92 (0.23) is better than 73.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.5
Altman-Z 2.11
ROIC/WACCN/A
WACC7.59%
S92.DE Yearly LT Debt VS Equity VS FCFS92.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • S92 has a Current Ratio of 1.31. This is a normal value and indicates that S92 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of S92 (1.31) is comparable to the rest of the industry.
  • S92 has a Quick Ratio of 1.31. This is a bad value and indicates that S92 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • S92's Quick ratio of 0.74 is on the low side compared to the rest of the industry. S92 is outperformed by 72.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.74
S92.DE Yearly Current Assets VS Current LiabilitesS92.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. S92.DE Growth Analysis

3.1 Past

  • S92 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -152.15%.
  • S92 shows a decrease in Revenue. In the last year, the revenue decreased by -0.91%.
  • Measured over the past years, S92 shows a quite strong growth in Revenue. The Revenue has been growing by 10.83% on average per year.
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.08%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-18.93%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.59% on average over the next years. This is a very strong growth
  • S92 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.48% yearly.
EPS Next Y-53.98%
EPS Next 2Y61.14%
EPS Next 3Y41.7%
EPS Next 5Y34.59%
Revenue Next Year-0.33%
Revenue Next 2Y2.5%
Revenue Next 3Y3.1%
Revenue Next 5Y3.48%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
S92.DE Yearly Revenue VS EstimatesS92.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
S92.DE Yearly EPS VS EstimatesS92.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. S92.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for S92. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 25.96, the valuation of S92 can be described as expensive.
  • Based on the Price/Forward Earnings ratio, S92 is valued a bit cheaper than the industry average as 65.75% of the companies are valued more expensively.
  • S92 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.96
S92.DE Price Earnings VS Forward Price EarningsS92.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • S92's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. S92 is cheaper than 79.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.58
EV/EBITDA N/A
S92.DE Per share dataS92.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as S92's earnings are expected to grow with 41.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.14%
EPS Next 3Y41.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. S92.DE Dividend Analysis

5.1 Amount

  • No dividends for S92!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

S92.DE Fundamentals: All Metrics, Ratios and Statistics

SMA SOLAR TECHNOLOGY AG

FRA:S92 (4/15/2026, 5:35:30 PM)

52.5

+3.2 (+6.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-04
Earnings (Next)05-13
Inst Owners22.29%
Inst Owner ChangeN/A
Ins Owners21.31%
Ins Owner ChangeN/A
Market Cap1.82B
Revenue(TTM)1.52B
Net Income(TTM)-181.13M
Analysts70.91
Price Target39.2 (-25.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.01%
Min EPS beat(2)0.99%
Max EPS beat(2)35.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-6.68%
Max Revenue beat(4)1.03%
Revenue beat(8)3
Avg Revenue beat(8)-3.92%
Revenue beat(12)6
Avg Revenue beat(12)-1.61%
Revenue beat(16)8
Avg Revenue beat(16)9.53%
PT rev (1m)33.17%
PT rev (3m)57.31%
EPS NQ rev (1m)34.57%
EPS NQ rev (3m)20.77%
EPS NY rev (1m)10.4%
EPS NY rev (3m)91.4%
Revenue NQ rev (1m)-2.21%
Revenue NQ rev (3m)6.69%
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)6.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.96
P/S 1.2
P/FCF 19.58
P/OCF 12.74
P/B 4.98
P/tB 6.76
EV/EBITDA N/A
EPS(TTM)-3.39
EYN/A
EPS(NY)2.02
Fwd EY3.85%
FCF(TTM)2.68
FCFY5.11%
OCF(TTM)4.12
OCFY7.85%
SpS43.69
BVpS10.53
TBVpS7.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -13.87%
ROE -49.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.09%
FCFM 6.14%
ROA(3y)-2.53%
ROA(5y)-0.95%
ROE(3y)-12.65%
ROE(5y)-6.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.4%
GM growth 5Y-4.74%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.5
Debt/EBITDA N/A
Cap/Depr 40.66%
Cap/Sales 3.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.74
Altman-Z 2.11
F-Score3
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)120.27%
Cap/Depr(5y)127.39%
Cap/Sales(3y)4.53%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.08%
EPS Next Y-53.98%
EPS Next 2Y61.14%
EPS Next 3Y41.7%
EPS Next 5Y34.59%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-18.93%
Revenue Next Year-0.33%
Revenue Next 2Y2.5%
Revenue Next 3Y3.1%
Revenue Next 5Y3.48%
EBIT growth 1Y-83.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.18%
EBIT Next 3Y52.46%
EBIT Next 5Y26.42%
FCF growth 1Y143.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y214.58%
OCF growth 3Y70.86%
OCF growth 5YN/A

SMA SOLAR TECHNOLOGY AG / S92.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SMA SOLAR TECHNOLOGY AG?

ChartMill assigns a fundamental rating of 3 / 10 to S92.DE.


What is the valuation status of SMA SOLAR TECHNOLOGY AG (S92.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to SMA SOLAR TECHNOLOGY AG (S92.DE). This can be considered as Fairly Valued.


How profitable is SMA SOLAR TECHNOLOGY AG (S92.DE) stock?

SMA SOLAR TECHNOLOGY AG (S92.DE) has a profitability rating of 1 / 10.


How financially healthy is SMA SOLAR TECHNOLOGY AG?

The financial health rating of SMA SOLAR TECHNOLOGY AG (S92.DE) is 5 / 10.


What is the expected EPS growth for SMA SOLAR TECHNOLOGY AG (S92.DE) stock?

The Earnings per Share (EPS) of SMA SOLAR TECHNOLOGY AG (S92.DE) is expected to decline by -53.98% in the next year.